Chronic active hepatitis: the challenge for a new nomenclature.
Czaja AJ.
Ann Intern Med. 1993 Sep 15;119(6):510-7. doi: 10.7326/0003-4819-119-6-199309150-00011.
Chronic active hepatitis and related disorders.
Larcher V.
Clin Gastroenterol. 1986 Jan;15(1):173-98.
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial.
Shao YY, Chen CT, Chuang CH, Su TH, Ho MC, Tseng TC, Liu TH, Wu TC, Cheng AL, Hsu CH.
Br J Cancer. 2025 May;132(9):822-827. doi: 10.1038/s41416-025-02978-7. Epub 2025 Mar 24.
Diabetes mellitus in chronic active hepatitis and cirrhosis.
Kingston ME, Ali MA, Atiyeh M, Donnelly RJ.
Gastroenterology. 1984 Sep;87(3):688-94.
Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection.
Meng JP, Luo P, Bai Y, Cui F.
J Int Med Res. 2020 Jan;48(1):300060519884157. doi: 10.1177/0300060519884157.
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.
Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Aricò S, Calzia R, Picciotto A, Colombo M, Popper H.
Ann Intern Med. 1983 Apr;98(4):437-41. doi: 10.7326/0003-4819-98-4-437.
Sarcoidosis after interferon therapy for chronic active hepatitis C.
Teragawa H, Hondo T, Takahashi K, Watanabe H, Ohe H, Hattori N, Watanabe Y, Amano H, Hino F, Ohbayashi M, Urushihara T, Yonehara S.
Intern Med. 1996 Jan;35(1):19-23. doi: 10.2169/internalmedicine.35.19.
Long-term follow-up of anti-HBe-positive chronic active hepatitis B.
Fattovich G, Brollo L, Alberti A, Pontisso P, Giustina G, Realdi G.
Hepatology. 1988 Nov-Dec;8(6):1651-4. doi: 10.1002/hep.1840080630.
Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis.
Manfredi R, Dentale N, Calza L.
Int J STD AIDS. 2012 Mar;23(3):e48-50. doi: 10.1258/ijsa.2009.009333.
Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.
Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC.
J Clin Immunol. 2010 Jan;30(1):60-7. doi: 10.1007/s10875-009-9328-2. Epub 2009 Sep 10.
